Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02020720 · ClinicalTrials.gov registry record · Early Phase 1
18F-DOPA-PET in Planning Surgery in Patients With Gliomas
A Early Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 72
- Enrollment target
NCT02020720: Completed Early Phase 1 study, sponsored by Mayo Clinic.
NCT02020720 is a Early Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02020720, a Early Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 72 participants
- Enrollment target
Study Summary
This pilot clinical trial studies fluorine F 18 fluorodopa (18F-DOPA)-positron emission tomography (PET) in planning surgery in patients with gliomas. New imaging procedures, such as 18F-DOPA-PET scan, may help find gliomas and may help in planning surgery.
Interventions
- PROCEDURE Computed Tomography
- PROCEDURE Biopsy
- OTHER Laboratory Biomarker Analysis
- PROCEDURE Diffusion Weighted Imaging
- DRUG Fluorine F 18 Fluorodopa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2014-01-22 |
| Est. Completion | 2024-01-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02020720
The ClinicalTrials.gov registry entry for NCT02020720 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Computed Tomography is the first listed.
NCT02020720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02020720 about?
NCT02020720 is a clinical study titled "18F-DOPA-PET in Planning Surgery in Patients With Gliomas". This pilot clinical trial studies fluorine F 18 fluorodopa (18F-DOPA)-positron emission tomography (PET) in planning surgery in patients with gliomas. New imaging procedures, such as 18F-DOPA-PET scan, may help find gliomas and may help in planning surgery.
What is the current status of trial NCT02020720?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 72 participants. The study started on 2014-01-22. Estimated completion is 2024-01-10.
What interventions are being tested in trial NCT02020720?
The interventions under investigation include: Computed Tomography (PROCEDURE), Biopsy (PROCEDURE), Laboratory Biomarker Analysis (OTHER), Diffusion Weighted Imaging (PROCEDURE), Fluorine F 18 Fluorodopa (DRUG).
Who is sponsoring clinical trial NCT02020720?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.